Twist-1 is a transcription factor that helps cancer cells spread by triggering Epithelial to Mesenchymal Transition (EMT), a process that makes tumor cells more mobile. A key feature of EMT is the loss of E-cadherin (which keeps cells together) and the gain of N-cadherin (which promotes movement), both influenced by Twist-1. This protein also supports cancer growth by promoting blood vessel formation (angiogenesis), helping cancer cells escape the bloodstream (extravasation), and preventing cell death.
Twist-1 is often overactive or chemically modified (hypermethylated) in many cancers, including colorectal cancer. Its activity is controlled by several signaling pathways (WNT, NOTCH, TGFβ, and RTKs), which together drive EMT. High Twist-1 levels in colorectal cancer are linked to poor prognosis, making it a potential target for new treatments.
Why is this Research Interesting?
This research is important because it highlights Twist-1 as a key player in colorectal cancer progression. Understanding how Twist-1 works can help develop therapies that block its activity, potentially stopping cancer from spreading and improving patient survival.


